Capricor Therapeutics announced that the Company is set to join the Russell 2000 Index and the broad-market Russell 3000 Index, effective at the open of U.S. equity markets today, July 1, 2024.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CAPR:
- Capricor Therapeutics Set to Join Russell 2000® and Russell 3000® Indexes
- Capricor Therapeutics Announces Long-Term Benefit of Deramiocel (CAP-1002) in Both Skeletal Muscle and Cardiac Function in the HOPE-2 OLE Study in Duchenne Muscular Dystrophy
- Capricor announces three-year safety, efficacy results from HOPE-2 OLE study
- CORRECTION: Capricor Therapeutics
- Capricor Therapeutics announces Pre-BLA meeting for CAP-1002